Treatment with a central stimulant may reduce the risk of suicide attempt and nonsuicidal self-injury in adults with a dual diagnosis of bipolar disorder and attention-deficit/hyperactivity disorder (ADHD), according to a study published online in Therapeutic Advances in Psychopharmacology.